Recombinant Human DDAH1 Protein, CF
Recombinant Human DDAH1 Protein, CF Summary
Product Specifications
Ala2-Ser285, with an N-terminal Met and 6-His tag
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
6530-DA
| Formulation | Supplied as a 0.2 μm filtered solution in Tris, NaCl, EDTA, DTT and Glycerol. |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Assay Procedure
- Assay Buffer: 50 mM Tris, 5 mM 1,10-phenanthroline, 5 mM TCEP, pH 8.5
- 1,10-phenanthroline (Sigma, Catalog # 320056), 0.6 M stock in DMSO
- Tris(2-carboxyethyl)phosphine (TCEP) (Calbiochem, Catalog # 580560), 0.5 M in deionized water
- Recombinant Human Dimethylarginine Dimethylaminohydrolase 1/DDAH1 (rhDDAH1) (Catalog # 6530‑DA)
- Asym-dimethylarginine (ADMA) (Sigma, Catalog # D4268), 100 mM stock in deionized water
- 2,3-Butanedione monoxime (DAMO) (Sigma, Catalog # B0753)
- Thiosemicarbazide (Sigma, Catalog # 89050)
- o-Phosphoric acid, 85% (Fisher, Catalog # A242)
- Sulfuric acid (Fisher, Catalog # A300)
- Ammonium iron (III) sulfate dodecahydrate (Sigma, Catalog # 221260)
- L-Citrulline (Sigma, Catalog #C7269), 20 mM stock in deionized water
- 96-well Clear Plate (Costar, Catalog # 92592)
- Plate Reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
- Prepare Color Developing Reagent A (80 mM DAMO, 2 mM Thiosemicarbazide) in deionized water.
- Prepare Color Developing Reagent B (17.35% (v/v) Phosphoric Acid, 33.7% (v/v) Sulfuric Acid, 0.765 mg/mL Ammonium Iron Sulfate) in deionized water.
- Dilute rhDDAH1 to 40 ng/µL in Assay Buffer.
- Dilute ADMA to 20 mM in Assay Buffer.
- Dilute 20 mM L-Citrulline stock to 1000 µM in Assay Buffer. This is the first point of the standard curve.
- Continue standard curve by performing six one-half serial dilutions of the 1000 µM L-Citrulline in Assay Buffer. The standard curve has a range of 0.625 to 40 nmol per well.
- Pipet 150 µL of each point of the standard curve into microtubes.
- Combine 75 µL of 40 ng/µL rhDDAH1 with 75 µL of 20 mM ADMA in microtubes. Include a Substrate Blank containing Assay Buffer in place of rhDDAH1.
- Incubate reaction, blank, and standard curve for 1 hour at 37 °C.
- Prepare Color Developing Reagent C (1 part Reagent A: 3 parts Reagent B).
- Add 600 μL of Color Developing Reagent C to reaction, blank, and standard curve tubes.
- Heat the tubes at 95-100 °C in a heating block for 15 minutes.
- Cool tubes at room temperature for 5 minutes.
- Load 200 μL into wells.
- Read plate at 540 nm (absorbance) in endpoint mode.
- Calculate specific activity:
|
Specific Activity (pmol/min/µg) = |
Product* (nmol) x (1000 pmol/nmol) |
| Incubation time (min) x amount of enzyme (µg) |
*Derived from the L-Citrulline standard curve using linear fitting and adjusted for Substrate Blank.
Per Well:- rhDDAH1: 0.8 μg
- ADMA: 2 mM
Reconstitution Calculator
Background: Dimethylarginine Dimethylaminohydrolase 1/DDAH1
Dimethylarginine Dimethylaminohydrolase (DDAH) metabolizes asymmetric dimethyl arginine (ADMA) to L-citrulline and dimethylamine, and NG-monomethyl arginine (MMA) to L-citrulline and monomethylamine (1). Two members of the DDAH family have been identified in humans. DDAH1 is widely expressed, especially in liver and kidney. DDAH2 predominates in vascular endothelium and expressed selectively in kidney (2). It is also expressed in immune tissues including spleen, thymus, peripheral leukocytes, lymph nodes, and bone marrow. Over 90 % of endogenous ADMA is metabolized by DDAH with the remainder excreted (3). ADMA and MMA are endogenous inhibitors of nitric oxide synthase (NOS). Thus, enzymes of the DDAH family play a key role in vascular function through the turnover of methylated arginine (4). It has been observed that genetic variation in the DDAH1 and DDAH2 genes is significantly associated with serum ADMA levels (5).
- Tadashi, O. et al. (1989) J. Biol. Chem. 264:10205.
- Tran, C. T. et al. (2000) Genomics 68:101.
- Tran, C. T. et al. (2003) Atheroscler. Suppl. 4:33.
- Leiper, J. et al. (2007) Nat. Med. 13:198.
- Abhary, S. et al. (2010) PNAS PLoS One. 5:e9462.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human DDAH1 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human DDAH1 Protein, CF and earn rewards!
Have you used Recombinant Human DDAH1 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
